Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of LY2835219 in Japanese Patients with Advanced Cancer
jRCT2080222332Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of abemaciclib in Nonhematologic neoplasms and lymphoma, sponsored by Eli Lilly and Company. Started Dec 2013; status: completed.
02
Drugs
abemaciclib
03
Conditions
Nonhematologic neoplasmslymphoma
Beyond the preview
Go deeper on jRCT2080222332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222332.